
A biopharmaceutical company engaged in the development of products for the treatment of patients with cancer.
The best Bull and Bear pitches based on recency and number of recommendations.
For those who missed the hint in my last red thumb, I was predicting the hefty dilutive financing that swatted down the share price a couple of weeks ago. Now the share price is back over 1.9 just days after the company sold 40M in stock at 1.6.… More
Read the most recent pitches from players about YMI.DL.
Find the members with the highest scoring picks in YMI.DL.
See what the Wall Street professionals think, according to their public statements and filings.